BostonGene reposted this
Meet us today at hubXchange's Immuno-Oncology Xchange Boston 2024! Be sure to attend the roundtable discussion, "Multiomic immune biomarker selection for novel IO response and toxicity assessment: tissue, blood, plasma, or all of the above?" led by Michael Goldberg, PhD, VP, Research & Development at BostonGene. This session will explore using immune biomarkers to enhance drug development and patient outcomes. The focus will be on current applications, technological advancements, novel approaches and necessary validation and regulatory processes, highlighting how these strategies can improve therapeutic results and personalize treatments. https://lnkd.in/ej7CAYTT
